1.Management of Acute Stroke Patients Amid the Coronavirus Disease 2019 Pandemic: Scientific Statement of the Korean Stroke Society
Beom Joon KIM ; Eu Suk KIM ; Myoung Jin SHIN ; Hong Bin KIM ; Hee Young LEE ; Keun-Sik HONG ; Hong-Kyun PARK ; Jun LEE ; Sung-Il SOHN ; Yang-Ha HWANG ; Sang-Bae KO ; Jong-Moo PARK ; Joung-Ho RHA ; Sun U. KWON ; Jong S. KIM ; Ji Hoe HEO ; Byung Chul LEE ; Byung-Woo YOON ; Hee-Joon BAE
Journal of Stroke 2020;22(2):203-205
		                        		
		                        		
		                        		
		                        	
2.Mechanical thromboprophylaxis is sufficient to prevent the lower extremity deep vein thrombosis after kidney transplantation.
Kang Woong JUN ; Keun Myoung PARK ; Mi Hyeong KIM ; Jeong Kye HWANG ; Soon Chul PARK ; In Sung MOON ; Byung Ha CHUNG ; Bum Soon CHOI ; Chul Woo YANG ; Yong Soo KIM ; Ji Il KIM
Annals of Surgical Treatment and Research 2014;87(1):28-34
		                        		
		                        			
		                        			PURPOSE: Deep vein thrombosis (DVT) is a severe and common complication that occurs after the major operation. Despite the commonality of DVT there is limited data on the incidence of DVT after kidney transplantation (KT). Furthermore, most studies have been retrospective in design and were conducted in western countries. The aim of this study was to evaluate the incidence of lower extremity DVT with mechanical thromboprophylaxis within 1 month of KT in Korea. METHODS: A total of 187 consecutive patients who underwent KT were included in this study. Patients used a graduated elastic stocking (n = 93) or an intermittent pneumatic compression device (n = 94) to prevent DVT. The frequency of DVT during the first month after KT was evaluated using serial color duplex ultrasound on postoperative days 7 +/- 2, 14 +/- 2, and 28 +/- 3. All patients were tested for eight thrombophilic factors before KT. RESULTS: DVT occurred in four patients (2.1%) during the first month after KT. All DVT developed in the graduated elastic stocking group. Interestingly, none of the patients had the factor V Leiden mutation or the prothrombin gene 20210A mutation. CONCLUSION: The incidence of DVT in this study was relatively lower than that of western populations. We did not encounter a factor V Leiden mutation or a prothrombin gene 20210A mutation in our study population. These findings suggest that inherited thrombophilic risk factors may be partially responsible for the difference in DVT incidence rates between different nationalities and/or ethnicities.
		                        		
		                        		
		                        		
		                        			Ethnic Groups
		                        			;
		                        		
		                        			Factor V
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Kidney Transplantation*
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Lower Extremity*
		                        			;
		                        		
		                        			Prothrombin
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Stockings, Compression
		                        			;
		                        		
		                        			Ultrasonography
		                        			;
		                        		
		                        			Venous Thrombosis*
		                        			
		                        		
		                        	
3.Comparison of Clinical Manifestation and Laboratory Findings between H1N1 and Influenza B Infection.
Su Hee KIM ; Chul Hyue PARK ; Kyoung HUH ; Gyu Hong SHIM ; Hyo Bin KIM ; Su Jeong YOU ; Young Whan SONG ; Ju Young CHUNG ; Mi Jung PARK ; Chang Keun KIM ; Myoung Jae CHEY ; Ja Wook KOO ; Sang Woo KIM
Pediatric Allergy and Respiratory Disease 2012;22(1):64-70
		                        		
		                        			
		                        			PURPOSE: Influenza virus is one of the most important viruses that cause the respiratory infection seasonally. In April 2009, H1N1 was detected in America and Mexico and then there was pandemic in Korea. We investigated the difference of clinical and laboratory findings between the infections of H1N1 and Influenza B. METHODS: We have retrospectively studied the patients under age of 15 years who visited Inje University Sanggye Paik Hospital from August 2009 to April 2010. Evaluation for influenza infection was performed by rapid antigen test or multiplex reverse transcriptase polymerase chain reaction. Complete blood count with differential counts, C-reactive protein and chest X-ray were checked. RESULTS: Enrolled patients were 2,226 in H1N1-infected group and 288 in influenza B-infected group. Seasonal variation was that H1N1 in autumn and winter but influenza B in spring. The male-to-female sex ratio was same as 1.23 in each group. The mean age of H1N1-infected group was higher than influenza B-infected group (P<0.001). Fever was developed similarly in both groups (P=0.114). However, cough, sputum, rhinorrhea, vomiting, diarrhea, and headache were more prevalent in influenza B infection compared to H1N1 infection (P<0.001). Pneumonia development and admission rate were higher in influenza B infection compared to H1N1 infection (P<0.001, respectively). CONCLUSION: Although H1N1 infection spread rapidly, H1N1 caused not so severe symptoms than influenza B. Because of the possibility that influenza epidemic will develop repeatedly in the future, we need to evaluate more about different characteristics depending on the virus subtype and prepare for them.
		                        		
		                        		
		                        		
		                        			Americas
		                        			;
		                        		
		                        			Blood Cell Count
		                        			;
		                        		
		                        			C-Reactive Protein
		                        			;
		                        		
		                        			Cough
		                        			;
		                        		
		                        			Diarrhea
		                        			;
		                        		
		                        			Fever
		                        			;
		                        		
		                        			Headache
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Influenza, Human
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Mexico
		                        			;
		                        		
		                        			Orthomyxoviridae
		                        			;
		                        		
		                        			Pandemics
		                        			;
		                        		
		                        			Pneumonia
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Reverse Transcriptase Polymerase Chain Reaction
		                        			;
		                        		
		                        			Seasons
		                        			;
		                        		
		                        			Sex Ratio
		                        			;
		                        		
		                        			Sputum
		                        			;
		                        		
		                        			Thorax
		                        			;
		                        		
		                        			Viruses
		                        			;
		                        		
		                        			Vomiting
		                        			
		                        		
		                        	
4.Ten year outcomes after bypass surgery in aortoiliac occlusive disease.
Gwan Chul LEE ; Shin Seok YANG ; Keun Myoung PARK ; Yangjin PARK ; Young Wook KIM ; Kwang Bo PARK ; Hong Suk PARK ; Young Soo DO ; Dong Ik KIM
Journal of the Korean Surgical Society 2012;82(6):365-369
		                        		
		                        			
		                        			PURPOSE: Most outcome studies of bypass surgery are limited to five years of follow-up. However, as human life expectancy has increased, analyses of more long-term outcomes are needed. The aim of this study is to evaluate 10-year outcomes of anatomical bypasses in aortoiliac occlusive disease. METHODS: From 1996 to 2009, 92 patients (82 males and 10 females) underwent aortic anatomical bypasses to treat aortoiliac occlusive disease at Samsung Medical Center. The patients were reviewed retrospectively. Kaplan-Meier survival analyses were performed using PASW ver. 18.0 (IBM Co). RESULTS: A total of 72 patients (78.3%) underwent aorto-femoral bypasses (uni- or bi-femoral), 15 patients (16.3%) underwent aorto-iliac bypasses (uni- or bi-iliac), and 5 patients (5.4%) underwent aorto-iliac and aorto-femoral bypasses. The overall primary patency rates of the 92 patients were 86.2% over 5 years and 77.6% over 10 years. The 10-year limb salvage rate and overall survival rate were 97.7% and 91.7%, respectively. CONCLUSION: The overall patency rates of bypass graft and limb salvage rates decreased as time passed. The analysis of results after bypass surgery to treat arterial occlusive disease will be needed to extend for 10 years of follow-up.
		                        		
		                        		
		                        		
		                        			Arterial Occlusive Diseases
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Leriche Syndrome
		                        			;
		                        		
		                        			Life Expectancy
		                        			;
		                        		
		                        			Limb Salvage
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Outcome Assessment (Health Care)
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Survival Rate
		                        			;
		                        		
		                        			Transplants
		                        			
		                        		
		                        	
5.The Factors Associated with the Decision of r-tPA Use in Acute Ischemic Stroke Patients Aged 80 Years or Older.
Min Gyeong JEONG ; Yerim KIM ; Yeo Jin KIM ; Mi Sun OH ; Kyung Ho YU ; Byung Chul LEE ; Ju Hun LEE ; Jee Hyun KWON ; Sun Uck KWON ; Sung Hyuk HEO ; Jay Chol CHOI ; Hyung Min KWON ; Jong Moo PARK ; Eung Gyu KIM ; Joung Ho RHA ; Hee Kwon PARK ; Hee Joon BAE ; Moon Ku HAN ; Keun Sik HONG ; Yong Jin CHO ; Man Seok PARK ; Ki Hyun CHO ; Hahn Young KIM ; Jun LEE ; Dong Eog KIM ; Soo Joo LEE ; Kyung Bok LEE ; Tai Hwan PARK ; Myoung Jin CHA ; Ji Hoe HEO ; Hyo Suk NAM ; Jae Kwan CHA ; Chul Ho KIM ; Byung Woo YOON
Korean Journal of Stroke 2011;13(2):79-84
		                        		
		                        			
		                        			BACKGROUND: Small proportions of all the elderly stroke patients receive recombinant tissue plasminogen activator (r-tPA) therapy, although old age is not a proven contraindication to intravenous thrombolytic therapy for acute ischemic stroke. The purpose of this study was to identify reasons for exclusion from r-tPA therapy and factors associated with the decision of r-tPA use in elderly patients with acute ischemic stroke. METHODS: From the acute stroke registries of 22 domestic university hospitals taking the r-tPA therapy from January 2007 to May 2010, we extracted data of all acute ischemic stroke patients who were aged 80 or over and arrived within onset 3 hours. For all patients, we assessed the eligibility of r-tPA therapy using National Institute of Neurological Disorders and Stroke (NINDS) r-tPA trial criteria. For eligible patients, we compared all clinical variables between patients who were treated with r-tPA and those who were not, and analyzed potential factors related to the decision of r-tPA use. RESULTS: A total of 494 patients were included in this study. 255 patients (51.6%) were excluded by NINDS r-tPA trial criteria and the major reasons for exclusion were minor neurological deficit (53.7%) and clinical improvement (17.3%). Among 239 patients who were eligible for r-tPA, 162 (32.8%) patients received r-tPA and 77 (15.6%) did not. Multivariable analysis showed that younger age, shorter time-delay from onset to admission, non-smoker, no history of prior stroke, good pre-stroke functional status and severe initial neurological deficit were independently associated with the decision of r-tPA use in the elderly stroke patients predictors for r-tPA treatment. CONCLUSION: In very elderly patients, mild neurological deficit on arrival and rapid clinical improvement in neurological symptoms were the main reasons for exclusion from thrombolytic therapy.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Hospitals, University
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			National Institute of Neurological Disorders and Stroke
		                        			;
		                        		
		                        			Registries
		                        			;
		                        		
		                        			Stroke
		                        			;
		                        		
		                        			Thrombolytic Therapy
		                        			;
		                        		
		                        			Tissue Plasminogen Activator
		                        			
		                        		
		                        	
6.The effect of ginsenoside Rk1 in junctional protein of severe preeclamptic placenta.
Seung Chul LIM ; Yong Sun MAENG ; Ja Young KWON ; Myoung Hwa KANG ; Jeong Hye HYANG ; Young Han KIM ; Young Keun KWON ; Yong Won PARK
Korean Journal of Obstetrics and Gynecology 2009;52(3):301-308
		                        		
		                        			
		                        			OBJECTIVE: To investigate the differential expression of junctional proteins in the normal and preeclamptic human placenta and the effect of ginsenoside Rk1 in junctional proteins. METHODS: Placental tissues from 10 women with severe preeclampsia and 5 normal women were collected at the time of their cesarean section. Five of 10 preeclamptic women were complicated with intrauterine growth restriction (IUGR). Immunohistochemistry and Western blotting was employed to localize junctional proteins (zo-1, occludin and plakoglobin) positive cells. The placental explant culture was performed to investigate if Rk1 can attenuate the expression of junctional proteins (zo-1, occluding and plakoglobin) induced by deferoxamine-induced hypoxia. Rk1 was treated at the day 3 and Western blot analysis was performed for protein quantification. RESULTS: There was no different expression of zo-1 and plakoglobin among all the study groups. Occludin showed negative at the endothelial cells of the terminal villi in both normal and preeclampsia groups. At the endothelial cells of the stem villi, occludin was detected in both normal and severe preeclamptic placenta with normal fetal growth. However, severe preeclampsia with IUGR were decreased expression of occludin at the endothelial cells of the stem villi. When we administered Rk1 to the placenta treated with DFO, expression of occludin was not different. CONCLUSION: The placental expression of zo-1 and plakoglobin were not different among the study groups, while that of occludin was significantly decreased at the endothelium of stem villi in severe preeclampsia with IUGR. Rk-1 showed no effect on the placental junctional proteins. These results suggest that occludin may play a role in pathophysiology of fetal growth restriction in utero.
		                        		
		                        		
		                        		
		                        			Anoxia
		                        			;
		                        		
		                        			Blotting, Western
		                        			;
		                        		
		                        			Cesarean Section
		                        			;
		                        		
		                        			Endothelial Cells
		                        			;
		                        		
		                        			Endothelium
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fetal Development
		                        			;
		                        		
		                        			Fetal Growth Retardation
		                        			;
		                        		
		                        			gamma Catenin
		                        			;
		                        		
		                        			Ginsenosides
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunohistochemistry
		                        			;
		                        		
		                        			Occludin
		                        			;
		                        		
		                        			Placenta
		                        			;
		                        		
		                        			Pre-Eclampsia
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Proteins
		                        			
		                        		
		                        	
7.Synthesis and Preliminary Evaluation of 9-(4-18FFluoro-3-hydroxymethylbutyl) Guanine (18FFHBG) in HSV1-tk Gene Transduced Hepatoma Cell.
Byung Seok MOON ; Tae Sup LEE ; Myoung Keun LEE ; Kyo Chul LEE ; Gwang Il AN ; Kwon Soo CHUN ; Ok Doo AWH ; Dae Yoon CHI ; Chang Woon CHOI ; Sang Moo LIM ; Gi Jeong CHEON
Nuclear Medicine and Molecular Imaging 2006;40(4):218-227
		                        		
		                        			
		                        			PURPOSE: The HSV1-tk reporter gene system is the most widely used system because of its advantage that direct monitoring is possible without the introduction of a separate reporter gene in case of HSV1-tk suicide gene therapy. In this study, we investigate the usefulness of the reporter probe (substrate), 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) for non-invasive reporter gene imaging using PET in HSV1-tk expressing hepatoma model. MATERIALS AND METHODS: Radiolabeled FHBG was prepared in 8 steps from a commercially available triester. The labeling reaction was carried out by NCA nucleophilic substitution with K[18F]/K2.2.2. in acetonitrile using N2-monomethoxytrityl-9-[4-(tosyl)-3-monomethoxytritylmethylbutyl]guanine as a precursor, followed by deprotection with 1 N HCl. Preliminary biological properties of the probe were evaluated with MCA cells and MCA-tk cells transduced with HSV1-tk reporter gene. In vitro uptake and release-out studies of [18F]FHBG were performed, and was analyzed correlation between [18F]FHBG uptake ratio according to increasing numeric count of MCA-tk cells and degree of gene expression. MicroPET scan image was obtained with MCA and MCA-tk tumor bearing Balb/c-nude mouse model. RESULTS: [18F]FHBG was purified by reverse phase semi-HPLC system and collected at around 16-18 min. Radiochemical yield was about 20-25% (corrected for decay), radiochemical purity was >95% and specific activity was around >55.5 GBq/micro mol. Specific accumulation of [18F]FHBG was observed in HSV1-tk gene transduced MCA-tk cells but not in MCA cells, and consecutive 1 hour release-out results showed more than 86% of uptaked [18F]FHBG was retained inside of cells. The uptake of [18F]FHBG was showed a highly significant linear correlation (R2=0.995) with increasing percentage of MCA-tk numeric cell count. In microPET scan images, remarkable difference of accumulation was observed for the two type of tumors. CONCLUSION: [18F]FHBG appears to be a useful as non-invasive PET imaging substrate in HSV1-tk expressing hepatoma model.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Carcinoma, Hepatocellular*
		                        			;
		                        		
		                        			Cell Count
		                        			;
		                        		
		                        			Gene Expression
		                        			;
		                        		
		                        			Genes, Reporter
		                        			;
		                        		
		                        			Genetic Therapy
		                        			;
		                        		
		                        			Guanine*
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Suicide
		                        			;
		                        		
		                        			Thymidine Kinase
		                        			
		                        		
		                        	
8.Effects of biphasic calcium phosphate on bone formation in human fetal osteoblasts.
Kye Chul SHIN ; Kil Young JANG ; Myoung Ku LEE ; Ho Sang YOON ; Jae Bong SONG ; Hyun A KIM ; Sung Hee PI ; Hyung Shik SHIN ; Hyung Keun YOU
The Journal of the Korean Academy of Periodontology 2005;35(1):77-85
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Bone Regeneration
		                        			;
		                        		
		                        			Calcium*
		                        			;
		                        		
		                        			Heterografts
		                        			;
		                        		
		                        			Humans*
		                        			;
		                        		
		                        			Osteoblasts*
		                        			;
		                        		
		                        			Osteogenesis*
		                        			
		                        		
		                        	
9.Apolipoprotein E Polymorphism in Patients with Myocardial Infarction.
Ho Seuk JEONG ; Sung Koo KIM ; Sang Cheol LEE ; Duk Won BANG ; Won Yong SHIN ; Young Keun ON ; Sung Choon CHOE ; Chul Hyun KIM ; Tae Myoung CHOI ; Min Su HYUN ; Eun Seuk JEON ; Young Joo KWON
Korean Circulation Journal 2002;32(1):31-37
		                        		
		                        			
		                        			BACKGROUND AND OBJECTIVES: In this study we investigated the association between the polymorphism of apolipoprotein E and the development of myocardial infarction, and assessed whether this polymorphism produces any changes of plasma lipid level. SUBJECTS AND METHODS: A total of 182 patients participated in this study and were divided into two groups; 91 patients with myocardial infarction (MI group) and 91 patients with no known heart disease (control group). For both groups we analyzed the clinical parameters, the changes of plasma lipid level and the degree of polymorphism of apolipoprotein E. RESULTS: Total cholesterol, triglyceride and LDL cholesterol levels were significantly higher in the MI group, while the HDL cholesterol level was significantly lower. Compared with the control group, the frequency of epsilon2 allele was significantly lower while that of epsilon3 allele was significantly higher in the MI group. As for the control group, the triglyceride level was significantly higher in the patients with epsilon 2 allele than in those without epsilon 2 allele, and the total cholesterol level was significantly higher in the patients with epsilon 4 allele than in those without epsilon 4 allele. In the MI group, the plasma lipid levels were not significantly different from those in the control group. CONCLUSION: We suggested that apolipoprotein E polymorphism could affect the lipid metabolism as well as the development of myocardial infarction. However further study is needed in patients with myocardial infarction.
		                        		
		                        		
		                        		
		                        			Alleles
		                        			;
		                        		
		                        			Apolipoproteins E
		                        			;
		                        		
		                        			Apolipoproteins*
		                        			;
		                        		
		                        			Cholesterol
		                        			;
		                        		
		                        			Cholesterol, HDL
		                        			;
		                        		
		                        			Cholesterol, LDL
		                        			;
		                        		
		                        			Heart Diseases
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lipid Metabolism
		                        			;
		                        		
		                        			Lipoproteins
		                        			;
		                        		
		                        			Myocardial Infarction*
		                        			;
		                        		
		                        			Plasma
		                        			;
		                        		
		                        			Triglycerides
		                        			
		                        		
		                        	
10.Immunohistochemical Staining of Insulin-like Growth Factor-1 in Human Lung Cancer cells of NSCLC and SCLC.
Ji Hyun PARK ; Myoung Jae KANG ; Heung Bum LEE ; Yong Chul LEE ; Yang Keun RHEE
Tuberculosis and Respiratory Diseases 2000;48(3):324-330
		                        		
		                        			
		                        			OBJECTIVE: Lung cancer arises after a series of morphological changes, which take several years to progress from normal epithelium to invasive cancer. Multiple molecular changes and growth factors factor production have been documented in lung cancers, both small cell and non-small cell types. Insulin-like growth factors(IGFs) are important mitogenic and anabolic peptides, both in vivo and in vitro, and are thought to be significant autocrine-paracrine factors involved in normal and malignant cell proliferation. In this study, we have investigated (delete) the degree of expression of IGF-1 on the immunohistochemical staining in human non-small cell lung cancer(NSCLC) cells and small cell lung cancer (SCLC) cells were investigated. METHODS: Immunohistochemical staining for IGF-1 was performed in 15 cases of small cell carcinoma, 15 cases of squamous cell carcinoma, 15 cases of adenocarcinoma, and 12 cases of bronchoalveolar carcinoma. RESULTS: The NSCLC cells showed significantly increased expression The expression of IGF-1 on the immunohistochemical staining significantly increased in NSCLC cells than in SCLC cells. CONCLUSION: These results suggest that IGF-1 are expressed the expression of IGF-1 in human lung cancer cells(.), and the (The) immunohistochemical staining of IGF-1 in lung cancer cell lines may help in differentiation of may assist in the differentiation of NSCLC and SCLC.
		                        		
		                        		
		                        		
		                        			Adenocarcinoma
		                        			;
		                        		
		                        			Carcinoma, Small Cell
		                        			;
		                        		
		                        			Carcinoma, Squamous Cell
		                        			;
		                        		
		                        			Cell Line
		                        			;
		                        		
		                        			Cell Proliferation
		                        			;
		                        		
		                        			Epithelium
		                        			;
		                        		
		                        			Humans*
		                        			;
		                        		
		                        			Insulin-Like Growth Factor I
		                        			;
		                        		
		                        			Intercellular Signaling Peptides and Proteins
		                        			;
		                        		
		                        			Lung Neoplasms*
		                        			;
		                        		
		                        			Lung*
		                        			;
		                        		
		                        			Peptides
		                        			;
		                        		
		                        			Small Cell Lung Carcinoma
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail